A previous meta-analysis involving eight randomized controlled trials (RCTs) verified that VD supplementation has a protective effect on insulin resistance (IR) and decreases serum alanine aminotransferase (ALT) in NAFLD patients (42). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.